P. Chanez (Marseille, France), C. Corrigan (London, United Kingdom)
Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells
M. Tsoumakidou, S. Tousa, E. Litsiou, N. Panagiotou, A. Panagiotou, M. Konstantinou, K. Potaris, C. Roussos, G. Xanthou, S. Zakynthinos (Athens, Greece)
|  |
Regulatory T cells in healthy and asthmatic subjects challenged with rhinovirus
S. Bal, M. van de Pol, P. Bresser, J. van der Zee, S. Johnston, P. Sterk, K. van der Sluijs, R. Lutter (Amsterdam, Netherlands; London, United Kingdom)
|  |
T-regulatory cells blood content in patients with asthma exacerbation
Z. Antanovich, V. Tsarev, N. Goncharova (Minsk, Belarus)
| |
Effector and regulatory lymphocytes in asthmatic pregnant women
L. Tamási, A. Bohács, A. Cseh, N. Eszes, J. Rigó, Jr., V. Müller, B. Vásárhelyi, G. Losonczy (Budapest, Hungary)
| |
Comparative characteristics of regulatory T cells populations between patients with bronchial asthma (BA) and COPD
E. Kremer, N. Kirillova, T. Perevozchikova, E. Fajt, I. Deev, L. Ogorodova (Tomsk, Russian Federation)
| |
IL-17 and Th17-cells as markers of disease progression in pediatric allergic diseases. A therapeutic approach in an "in vitro" models
M. Profita, L. Riccobono, R. Gagliardo, C. DiSano, A. M. Montalbano, G. D. Albano, A. Ferlisi, A. Bonanno, P. Chanez, M. Gjomarkaj, S. La Grutta (Palermo, Italy; Marseille, France)
| |
Lung and blood Th1 and Th17 responses against mycobacterial antigens in patients with pulmonary sarcoidosis
M. Ostadkarampour, A. Eklund, D. Moller, J. Grunewald, J. Wahlström (Stockholm, Sweden; Baltimore, United States Of America)
| |
Characterization of lymphocyte subsets in the lungs of smokers and patients with COPD
H. Forsslund, M. Mikko, J. Grunewald, A. Wheelock, J. Wahlström, M. Sköld (Stockholm, Sweden)
| |
TCR rearrangement in patients with eosinophilic lung disease
N. Freymond, V. Cottin, C. Khouatra, J. E. Kahn, N. Sivova, L. Prin, F. Legrand, J. F. Cordier (Lyon, Suresnes, Lille, France)
| |
Reduced expression of PPAR-alpha in bronchoalveolar lavage CD4+ T cells of sarcoidosis patients
M. Abo Al Hayja, A. Eklund, J. Grunewald, J. Wahlström (Stockholm, Sweden)
| |
Killer cells in asthma with incomplete airflow reversibility
C. Tubby, T. Harrison, I. Todd, L. Fairclough (Nottingham, United Kingdom)
| |
Collagen receptor α2β1 integrin is overexpressed on CD4 and CD8 peripheral blood T lymphocytes in long-lasting clinically stable asthma
J. Zuk, S. Bazan-Socha, J. Musial (Kracow, Poland)
| |
Different Th1, Th2, Th17 and Treg associated chemokine local pattern expression in lung in a murine model of allergic inflammation
Y. Lu, C. Malmhäll, M. Rådinger, M. Sjöstrand, S. O‘Neil, B. Lundbäck, J. Lötval, A. Bossios (Gothenburg, Sweden)
| |
T cell specific expression of a short splice variant of the tumor suppressor gene CYLD amplifies the development of allergic airway disease
S. Reuter, M. Becker, N. Dehzad, H. Martin, A. Waisman, M. Stassen, R. Buhl, C. Taube (Mainz, Germany)
| |
Apoptosis of peripheral blood lymphocytes in different periods of asthma
Z. Antanovich, V. Tsarev, N. Goncharova (Minsk, Belarus)
| |
Mechanism of long-lasting suppression against Th2 immune response in the lung by a novel antedrug TLR7 agonist
K. Eiho, H. Matsui, H. Hayashi, R. Inagaki, M. Aoki, M. Biffen, A. Leishman, S. Edwards, C. Murray, H. Takaku, H. Tomizawa, S. Akira, Y. Ueda (Osaka, Japan; Loughborough, United Kingdom)
| |
Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis
L. Greiff, C. Ahlstrom-Emanuelsson, G. Almqvist, M. Andersson, A. Cervin, J. Dolata, L. Eriksson, A. Kallen, P. Norlen, I. L. Sjolin, H. Widegren (Lund, Helsingborg, Sweden)
| |
Farm dust decreases Th2 driven allergic airway inflammation in mice: A role for airway TLR2 and TLR4?
P. Robbe, M. J. Blacquière, D. S. Postma, W. Timens, M. Geerlings, A. Bufe, O. Holst, E. von Mutuis, M. N. Hylkema (Groningen, Netherlands; Bochum, Borstel, Munich, Germany)
| |